confluent
layer
vero
cell
infect
strain
sarscov
hour
cell
harvest
inactiv
hour
inactiv
cell
cultur
dilut
dilut
healthi
blood
use
store
blood
specimen
patient
taken
week
onset
diseas
fulfil
clinic
case
definit
sar
diagnosi
subsequ
confirm
seroconvers
posit
sarscov
isol
control
blood
sampl
collect
two
addit
group
healthi
volunt
contact
sar
patient
healthi
doctor
nurs
contact
histori
hospit
without
symptom
sar
day
sampl
whole
blood
sampl
collect
vacuum
contain
edta
transfer
laboratori
rna
extract
immedi
sarscov
virion
known
concentr
sarscov
qualiti
assur
laboratori
nation
institut
control
pharmaceut
biolog
product
beij
china
serial
dilut
sarscovseroneg
human
plasma
predict
final
rna
concentr
copiesml
dilut
perform
suffici
number
aliquot
dilut
store
two
pair
primer
synthes
shanghai
sangon
compani
shanghai
china
accord
sarscov
strain
sequenc
tabl
plasmid
pgemt
promega
madison
wi
usa
contain
bp
fragment
sarscov
strain
downstream
promot
linear
pst
purifi
pcr
purif
kit
shanghai
biotech
shanghai
china
transcrib
rna
polymeras
use
express
larg
scale
rna
product
system
promega
madison
wi
usa
templat
dna
degrad
rnasefre
dnase
rna
transcript
purifi
twice
rneasi
kit
qiagen
gmbh
hilden
germani
rna
quantifi
spectrophotometr
dilut
divid
aliquot
store
dilut
sarscov
transcript
use
gener
standard
curv
singlecopi
assay
total
rna
extract
use
qiaamp
rna
blood
mini
kit
qiagen
gmbh
hilden
germani
accord
manufactur
instruct
blood
sampl
sampl
mix
buffer
el
lyse
red
cell
centrifug
minut
supernat
remov
deposit
collect
rna
extract
sampl
studi
volum
directli
use
rna
extract
rna
redissolv
diethyl
pirocarbon
depc
treat
water
contain
dnase
incub
minut
follow
inactiv
minut
rna
use
immedi
store
step
perform
biosafeti
level
laboratori
synthesi
cdna
undertaken
revers
transcript
rna
extract
minut
follow
incub
minut
solut
contain
mmoll
trishcl
ph
mmoll
kcl
mmoll
mmoll
dtt
hexam
random
primer
shanghai
sangong
compani
shanghai
china
superscript
ii
invitrogen
carlsbad
ca
usa
rnasin
promega
madison
wi
usa
mmoll
dntp
pcr
carri
mixtur
contain
complementari
dna
cdna
mmoll
trishcl
ph
mmoll
kcl
mmoll
dntp
taq
pol
promega
madison
wi
usa
forward
primer
revers
primer
cycl
amplif
second
second
second
undertaken
denatur
minut
amplifi
product
detect
agaros
gel
electrophoresi
sequenc
identif
undertaken
rtpcr
product
unmatch
amplif
two
pair
primer
forward
revers
sequenc
undertaken
abi
dna
sequenc
appli
biosystem
foster
citi
ca
usa
direct
serial
dilut
standard
sarscov
rna
contain
target
sequenc
rna
standard
sarscov
panel
rna
blood
sampl
sar
patient
rna
blood
sampl
healthi
individu
test
use
qfrtpcr
qfrtpcr
carri
mixtur
contain
rna
univers
pcr
master
mix
appli
biosystem
foster
citi
ca
usa
forward
primer
af
revers
primer
ar
probe
fluorometr
pcr
instrument
appli
biosystem
foster
citi
ca
usa
cycl
amplif
second
minut
fluoresc
record
perform
denatur
minut
minut
compar
sensit
two
pair
primer
serial
dilut
sarscov
posit
clinic
specimen
cell
cultur
test
dilut
sarscov
clinic
sampl
test
posit
primer
dilut
sarscov
clinic
sampl
test
posit
primer
assay
figur
sampl
test
posit
primer
sequenc
sequenc
shown
ident
publish
sarscov
sequenc
determin
specif
control
sampl
test
test
gave
neg
result
determin
sensit
standard
sarscov
panel
clinic
sampl
test
clinic
sampl
test
posit
standard
sarscov
panel
test
sampl
copiesml
sometim
test
posit
sampl
copiesml
alway
test
neg
determin
specif
control
sampl
test
sampl
test
neg
determin
dynam
rang
serial
dilut
standard
sarscov
rna
contain
target
sequenc
test
wide
linear
rang
begin
copi
extend
copi
control
plasmid
establish
least
copi
sometim
even
copi
target
rna
test
posit
assay
figur
demonstr
accuraci
qfrtpcr
assay
qfrtpcr
product
serial
dilut
standard
sarscov
rna
contain
target
sequenc
also
detect
pcrethidium
bromid
eb
stain
method
qfrtpcr
copi
faint
band
figur
studi
analyz
blood
sampl
patient
confirm
sar
use
seroconvers
posit
sarscov
isol
infect
vero
cell
mani
data
show
bloodborn
sarscov
load
may
quit
low
even
viremia
occur
altern
patient
may
even
develop
viremia
virus
propag
epitheli
tissu
lung
therefor
studi
select
sampl
posit
viru
isol
rtpcrbase
test
use
primer
pair
publish
reliabl
identif
method
avail
public
sensit
specif
method
howev
primer
publish
sarscov
locat
open
read
frame
sarscov
sens
rna
viru
target
fragment
near
termin
viru
genom
design
pair
primer
expect
amplifi
bp
length
cover
region
viru
basi
publish
sequenc
sarscov
pair
primer
publish
compar
primer
confirm
sensit
primer
serial
dilut
sarscov
clinic
sampl
use
compar
primer
primer
appear
greater
sensit
pcr
product
sampl
test
neg
primer
assay
posit
primer
assay
sequenc
match
correctli
sarscov
determin
specif
sampl
close
contact
healthi
medic
personnel
test
test
neg
result
suggest
primer
better
sensit
specif
determin
sensit
specif
dynam
rang
qfrtpcr
standard
sarscov
panel
clinic
sampl
control
sampl
serial
dilut
standard
sarscov
rna
contain
target
sequenc
subject
qfrtpcr
assay
result
show
assay
highli
sensit
specif
wide
linear
rang
primer
abl
distinguish
differ
concentr
rang
least
copi
sometim
even
copi
target
rna
test
posit
assay
standard
sarscov
panel
assay
consid
effici
rna
extract
deadlin
qfrtpcr
copiespcr
copiespcr
demonstr
accuraci
qfrtpcr
assay
compar
pcreb
stain
method
compar
pcreb
method
qfrtpcr
sensit
less
timeconsum
result
show
qfrtpcr
assay
suffici
sensit
specif
method
diagnos
symptomat
sarscov
infect
monitor
viru
load
